AAPL341.07+5.15 (+1.53%) ▲|ABBV264.34-0.78 (-0.29%) ▼|ABT101.29+0.22 (+0.22%) ▲|ACN176.11-1.30 (-0.73%) ▼|ADBE235.47-3.46 (-1.45%) ▼|AMAT485.00+10.75 (+2.27%) ▲|AMD630.63+1.37 (+0.22%) ▲|AMGN414.61+8.57 (+2.11%) ▲|AMT169.03+1.77 (+1.06%) ▲|AMZN249.67+0.29 (+0.12%) ▲|AVGO352.81+2.45 (+0.70%) ▲|AXP308.89+3.23 (+1.06%) ▲|BA198.07+1.27 (+0.65%) ▲|BAC56.70+0.67 (+1.20%) ▲|BKNG163.95+6.54 (+4.15%) ▲|BLK1,086.31+12.86 (+1.20%) ▲|BMY62.86+1.36 (+2.21%) ▲|BNY150.15-0.04 (-0.03%) ▼|BRK-B505.48+0.30 (+0.06%) ▲|C134.28+2.18 (+1.65%) ▲|CAT821.58+16.33 (+2.03%) ▲|CL86.06+0.74 (+0.87%) ▲|CMCSA21.91-0.22 (-0.99%) ▼|COF200.20+3.59 (+1.83%) ▲|COP127.30-2.04 (-1.58%) ▼|COST922.77+26.29 (+2.93%) ▲|CRM234.02-4.20 (-1.76%) ▼|CSCO106.70-0.27 (-0.25%) ▼|CVS89.13+4.08 (+4.80%) ▲|CVX204.45-1.20 (-0.58%) ▼|DE690.46-4.48 (-0.64%) ▼|DHR224.49+0.72 (+0.32%) ▲|DIS106.15+0.59 (+0.56%) ▲|DUK113.35+0.12 (+0.11%) ▲|EMR158.23+2.09 (+1.34%) ▲|FDX285.85+6.31 (+2.26%) ▲|GD336.72+0.43 (+0.13%) ▲|GE327.09+7.31 (+2.29%) ▲|GEV957.63+2.59 (+0.27%) ▲|GILD150.93+1.24 (+0.83%) ▲|GM82.63+2.06 (+2.56%) ▲|GOOG341.08+2.07 (+0.61%) ▲|GOOGL343.92+1.56 (+0.46%) ▲|GS935.45+12.16 (+1.32%) ▲|HD293.20+1.02 (+0.35%) ▲|HON212.55+0.76 (+0.36%) ▲|IBM225.51-1.55 (-0.68%) ▼|INTC123.00-4.39 (-3.45%) ▼|INTU275.79-1.34 (-0.48%) ▼|ISRG405.18+5.66 (+1.42%) ▲|JNJ271.22+0.54 (+0.20%) ▲|JPM343.06+4.50 (+1.33%) ▲|KO87.81-0.29 (-0.33%) ▼|LIN469.89+1.75 (+0.37%) ▲|LLY1,183.46+1.57 (+0.13%) ▲|LMT519.56-4.14 (-0.79%) ▼|LOW189.28+0.79 (+0.42%) ▲|LRCX315.21+8.05 (+2.62%) ▲|MA567.65+1.57 (+0.28%) ▲|MCD236.50-0.52 (-0.22%) ▼|MDLZ60.25-0.61 (-1.00%) ▼|MDT88.64+0.85 (+0.97%) ▲|META751.66-25.93 (-3.33%) ▼|MMM169.55+2.03 (+1.21%) ▲|MO68.82-0.06 (-0.09%) ▼|MRK148.78+0.80 (+0.54%) ▲|MS196.31-0.01 (-0.01%) ▼|MSFT516.17+18.24 (+3.66%) ▲|MU1,082.28+1.75 (+0.16%) ▲|NEE76.08+0.46 (+0.61%) ▲|NFLX71.15-0.58 (-0.80%) ▼|NKE35.75-0.24 (-0.67%) ▼|NOW135.62-2.16 (-1.57%) ▼|NVDA225.07+0.49 (+0.22%) ▲|ORCL137.10-2.44 (-1.75%) ▼|PEP128.63+0.48 (+0.37%) ▲|PFE28.67+0.26 (+0.92%) ▲|PG146.23+0.55 (+0.38%) ▲|PLTR189.67-2.92 (-1.52%) ▼|PM190.48-1.02 (-0.53%) ▼|QCOM201.97+7.71 (+3.97%) ▲|RTX189.40+0.79 (+0.42%) ▲|SBUX94.86+1.21 (+1.29%) ▲|SCHW99.03-0.46 (-0.46%) ▼|SO82.88-0.01 (-0.01%) ▼|SPG204.82+0.12 (+0.06%) ▲|T25.38-0.07 (-0.28%) ▼|TMO675.00-3.39 (-0.50%) ▼|TMUS165.43+0.08 (+0.05%) ▲|TSLA372.11-5.83 (-1.54%) ▼|TXN278.07+7.42 (+2.74%) ▲|UBER69.62+0.40 (+0.58%) ▲|UNH376.59+1.58 (+0.42%) ▲|UNP273.79-0.28 (-0.10%) ▼|UPS93.96+1.91 (+2.08%) ▲|USB59.33+0.93 (+1.59%) ▲|V367.38-0.60 (-0.16%) ▼|VZ47.08-0.24 (-0.51%) ▼|WFC82.97+0.79 (+0.96%) ▲|WMT107.98+0.39 (+0.36%) ▲|XOM160.59-1.55 (-0.96%) ▼|AAPL341.07+5.15 (+1.53%) ▲|ABBV264.34-0.78 (-0.29%) ▼|ABT101.29+0.22 (+0.22%) ▲|ACN176.11-1.30 (-0.73%) ▼|ADBE235.47-3.46 (-1.45%) ▼|AMAT485.00+10.75 (+2.27%) ▲|AMD630.63+1.37 (+0.22%) ▲|AMGN414.61+8.57 (+2.11%) ▲|AMT169.03+1.77 (+1.06%) ▲|AMZN249.67+0.29 (+0.12%) ▲|AVGO352.81+2.45 (+0.70%) ▲|AXP308.89+3.23 (+1.06%) ▲|BA198.07+1.27 (+0.65%) ▲|BAC56.70+0.67 (+1.20%) ▲|BKNG163.95+6.54 (+4.15%) ▲|BLK1,086.31+12.86 (+1.20%) ▲|BMY62.86+1.36 (+2.21%) ▲|BNY150.15-0.04 (-0.03%) ▼|BRK-B505.48+0.30 (+0.06%) ▲|C134.28+2.18 (+1.65%) ▲|CAT821.58+16.33 (+2.03%) ▲|CL86.06+0.74 (+0.87%) ▲|CMCSA21.91-0.22 (-0.99%) ▼|COF200.20+3.59 (+1.83%) ▲|COP127.30-2.04 (-1.58%) ▼|COST922.77+26.29 (+2.93%) ▲|CRM234.02-4.20 (-1.76%) ▼|CSCO106.70-0.27 (-0.25%) ▼|CVS89.13+4.08 (+4.80%) ▲|CVX204.45-1.20 (-0.58%) ▼|DE690.46-4.48 (-0.64%) ▼|DHR224.49+0.72 (+0.32%) ▲|DIS106.15+0.59 (+0.56%) ▲|DUK113.35+0.12 (+0.11%) ▲|EMR158.23+2.09 (+1.34%) ▲|FDX285.85+6.31 (+2.26%) ▲|GD336.72+0.43 (+0.13%) ▲|GE327.09+7.31 (+2.29%) ▲|GEV957.63+2.59 (+0.27%) ▲|GILD150.93+1.24 (+0.83%) ▲|GM82.63+2.06 (+2.56%) ▲|GOOG341.08+2.07 (+0.61%) ▲|GOOGL343.92+1.56 (+0.46%) ▲|GS935.45+12.16 (+1.32%) ▲|HD293.20+1.02 (+0.35%) ▲|HON212.55+0.76 (+0.36%) ▲|IBM225.51-1.55 (-0.68%) ▼|INTC123.00-4.39 (-3.45%) ▼|INTU275.79-1.34 (-0.48%) ▼|ISRG405.18+5.66 (+1.42%) ▲|JNJ271.22+0.54 (+0.20%) ▲|JPM343.06+4.50 (+1.33%) ▲|KO87.81-0.29 (-0.33%) ▼|LIN469.89+1.75 (+0.37%) ▲|LLY1,183.46+1.57 (+0.13%) ▲|LMT519.56-4.14 (-0.79%) ▼|LOW189.28+0.79 (+0.42%) ▲|LRCX315.21+8.05 (+2.62%) ▲|MA567.65+1.57 (+0.28%) ▲|MCD236.50-0.52 (-0.22%) ▼|MDLZ60.25-0.61 (-1.00%) ▼|MDT88.64+0.85 (+0.97%) ▲|META751.66-25.93 (-3.33%) ▼|MMM169.55+2.03 (+1.21%) ▲|MO68.82-0.06 (-0.09%) ▼|MRK148.78+0.80 (+0.54%) ▲|MS196.31-0.01 (-0.01%) ▼|MSFT516.17+18.24 (+3.66%) ▲|MU1,082.28+1.75 (+0.16%) ▲|NEE76.08+0.46 (+0.61%) ▲|NFLX71.15-0.58 (-0.80%) ▼|NKE35.75-0.24 (-0.67%) ▼|NOW135.62-2.16 (-1.57%) ▼|NVDA225.07+0.49 (+0.22%) ▲|ORCL137.10-2.44 (-1.75%) ▼|PEP128.63+0.48 (+0.37%) ▲|PFE28.67+0.26 (+0.92%) ▲|PG146.23+0.55 (+0.38%) ▲|PLTR189.67-2.92 (-1.52%) ▼|PM190.48-1.02 (-0.53%) ▼|QCOM201.97+7.71 (+3.97%) ▲|RTX189.40+0.79 (+0.42%) ▲|SBUX94.86+1.21 (+1.29%) ▲|SCHW99.03-0.46 (-0.46%) ▼|SO82.88-0.01 (-0.01%) ▼|SPG204.82+0.12 (+0.06%) ▲|T25.38-0.07 (-0.28%) ▼|TMO675.00-3.39 (-0.50%) ▼|TMUS165.43+0.08 (+0.05%) ▲|TSLA372.11-5.83 (-1.54%) ▼|TXN278.07+7.42 (+2.74%) ▲|UBER69.62+0.40 (+0.58%) ▲|UNH376.59+1.58 (+0.42%) ▲|UNP273.79-0.28 (-0.10%) ▼|UPS93.96+1.91 (+2.08%) ▲|USB59.33+0.93 (+1.59%) ▲|V367.38-0.60 (-0.16%) ▼|VZ47.08-0.24 (-0.51%) ▼|WFC82.97+0.79 (+0.96%) ▲|WMT107.98+0.39 (+0.36%) ▲|XOM160.59-1.55 (-0.96%) ▼|
16.9 C
New York
Sunday, September 27, 2026

Tag: information

Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an LP.8.1 angepassten COVID-19-Impfstoff in der Europäischen Union

NEW YORK und MAINZ, Deutschland, 25. Juli 2025 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass der Ausschuss für Humanarzneimittel (Committee for Medicinal Products for Human Use, „CHMP“) der Europäischen Arzneimittel-Agentur (European Medicines Agency, „EMA“) eine positive Beurteilung für die Marktzulassung (Marketing Authorization) des an LP.8.1 angepassten monovalenten COVID-19-Impfstoffs (COMIRNATY® LP.8.1) der Unternehmen für die aktive Immunisierung zur Vorbeugung von COVID-19 verursacht durch SARS-CoV-2 bei Personen ab 6 Monaten ausgesprochen hat. Die Anpassung basiert auf der Empfehlung der Notfall-Taskforce (Emergency Task Force, „ETF“) der EMA, die vorschlägt, COVID-19-Impfstoffe zu aktualisieren, um die LP.8.1-Variante für die Impfkampagne 2025-2026 abzudecken. Die Notfall-Taskforce erklärte: „Eine Anpassung an LP.8.1 wird dabei helfen, die Wirksamkeit der Impfstoffe gegen das sich fortlaufend weiterentwickelnde SARS-CoV-2 aufrechtzuerhalten.“2 

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The adaptation is based on the recommendation from the EMA’s Emergency Task Force (ETF) to update COVID-19 vaccines to target the LP.8.1 variant for the 2025-2026 season. The ETF stated that “targeting LP.8.1 will help maintain the effectiveness of the vaccines as SARS-CoV-2 continues to evolve.”2

MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MYMT 2026, MALAYSIA’S FIRST MEDICAL TOURISM YEAR

KUALA LUMPUR, Malaysia, July 25, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC)  launched Malaysia Year of Medical Tourism (MYMT) 2026 today at the...

MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MYMT 2026, MALAYSIA’S FIRST MEDICAL TOURISM YEAR

KUALA LUMPUR, Malaysia, July 25, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC)  launched Malaysia Year of Medical Tourism (MYMT) 2026 today at the...

Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained

SLOUGH, United Kingdom and RICHMOND, Va., July 25, 2025 /PRNewswire/ -- Further to the announcement made on June 2, 2025, Indivior PLC (Nasdaq: INDV)...

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Loomis Interim Report January – June 2025

STOCKHOLM, July 25, 2025 /PRNewswire/ -- A solid organic growth and strong operating margin We had a solid performance in the second quarter. Revenues reached SEK...

BW Energy: Invitation to Q2 2025 and half-year results presentation 01 August 

Invitation to Q2 2025 and half-year results presentation 01 August  

Sohu.com to Report Second Quarter 2025 Financial Results on August 4, 2025

BEIJING, July 25, 2025 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), a leading Chinese online media platform and game business group, will report its second quarter 2025...

Informal caregivers in Singapore seen as undertrained and overwhelmed

Despite nearly all professional caregivers agreeing that informal caregivers can help bridge the demand of caregiving in Singapore to a certain extent (30% large,...

Orange Belgium et Proximus signent un protocole d’accord (MoU) pour étendre le déploiement de la fibre et l’accès aux réseaux gigabit en Wallonie

Communiqué de presse
Embargo jusqu'au 25 juillet 2025 à 6h50
 Information réglementée – informations confidentielles

Orange Belgium and Proximus sign a Memorandum of Understanding to expand fiber deployment and increase access to gigabit networks in Wallonia

Press release
Embargo until 25 July 2025 at 6:50 am
 Regulated information – Inside information

Hexaware Delivers Solid Q2CY25 Revenue of USD 382.1 Mn, Up 8.6% YoY

Q2CY25 EBITDA Expansion of 156 bps YoY Q2CY25 EPS at INR 6.25 Increase of 37.7% YoY ISELIN, N.J., July 25, 2025 /PRNewswire/ -- Hexaware Technologies (NSE:...

Bitget KCGI 2025 Heats Up as Team Battle Kicks Off: Communities Unite, Rivalries Ignite

Bitget launches KCGI 2025 Team Battle with 6M USDT prize pool, global captains, and over 1,300 teams in fierce competition.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInformation